Open Government Canada
Special Review Decision SRD2021-02, Special Review Decision: Linuron and Its Associated End-use Products
Published by Health Canada | Santé Canada
About this dataset
This document presents the final regulatory decision for the special review of linuron. A reference list of information used as the basis for the proposed special review decision is included in PSRD2020-05. Therefore, the complete reference list of all information used in this final special review decision includes the information set out in PSRD2020-05.